1. Chewy reported better-than-expected Q2 earnings, driving shares higher in FY 2024; 2. The company's growth strategy, including veterinary clinics, led to a 65% Y/Y increase in adjusted EBITDA and a 6% rise in per-customer spend; 3. Chewy's valuation remains attractive, trading at a 55% discount to its 3-year average P/E ratio.